Baxalta Inc.

NYS: BXLT
Pharmaceuticals
Bannockburn IL
Title 1Chairman
Executive 1Dr. Wayne T. Hockmeyer, Ph.D., Chairman | Chairman
2015 Revenue (US$ Millions)$6,148
2014 Revenue (US$ Millions)$5,952
Revenue Growth (%)3.29%
Net Income (US$ Millions)$956
Common Shares Outstanding (Millions)$679
Earnings Per Share (US$)$1.40
Price To Earnings Ratio28.62
Total Equity (US$ Millions)$3,924
Return On Equity (%)16.63%
Long Term Debt (US$ Millions)$5,265
Debt To Equity Ratio (%)1.34%
Market Capitalization (US$ Millions)$26,513
Total Assets (US$ Millions)$12,329
Current Assets (US$ Millions)$4,708
Inventories (US$ Millions)$2,173
Current Liabilities (US$ Millions)$1,911
Cost of Goods Sold (US$ Millions)$2,386
Asset Turnover0.5
Inventory Turnover1.15